CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)

$39.11 0.13 (0.3335%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 72

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) News Sources

Celldex Therapeutics (CLDX) Reports Q1 Loss, Misses Revenue Estimates

07-05-2026

yahoo.com

Assessing Celldex Therapeutics (CLDX) Valuation After Recent Share Price Pullback And Mixed Signals

12-05-2026

yahoo.com

[Latest] Global Cholera Vaccine Market Size/Share Worth USD 649 Million by 2035 at a 7.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

19-05-2026

yahoo.com

Celldex Announces Multiple Upcoming Presentations from Leading Mast Cell Targeting Pipeline at the Upcoming 2026 European Academy of Allergy and Clinical Immunology Annual Congress

10-06-2026

yahoo.com

Celldex Presents Positive First-in-Human Results from Phase 1 Study of Novel Bispecific CDX-622 at the European Academy of Allergy and Clinical Immunology Annual Meeting

14-06-2026

yahoo.com

Celldex Presents Long-Term Barzolvolimab Results Demonstrating Sustained Off-Treatment Improvement in Angioedema in Patients with CSU at the European Academy of Allergy and Clinical Immunology Annual Meeting

14-06-2026

yahoo.com

Celldex Therapeutics (CLDX) Stock Valuation Check After Recent Share Price Momentum

15-06-2026

yahoo.com

QURE Was Just the Beginning: 5 Biotech Catalysts I’m Watching Now

19-06-2026

yahoo.com

Chronic Spontaneous Urticaria Market Heats Up as Pharma Companies Race to Address Unmet Needs | DelveInsight

24-06-2026

yahoo.com

Is Celldex Therapeutics, Inc. (CLDX) Stock Positioned for Growth Ahead of Potential 2027 Approval?

30-06-2026

yahoo.com

CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) Sentiment Trend

0 25 50 75 100 2 69 79 73 80 81 72 79 89 93 07-05-2026 12-05-2026 19-05-2026 10-06-2026 14-06-2026 15-06-2026 19-06-2026 24-06-2026 30-06-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) FAQs

toggle

What is the current price of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)?

The current price of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) is $39.11.


toggle

CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) absolute price change since previous trading day?

The absolute price change of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) since the previous trading day is $0.13.


toggle

CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) percentage price change since previous trading day?

The percentage price change of CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) since the previous trading day is 0.3335%.


toggle

What is the most recent average sentiment score for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)?

The most recent average sentiment score for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) is 72 out of 100.


toggle

What is the most recent average sentiment for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)?

The most recent sentiment for CELLDEX THERAPEUTICS INC (CLDX:NASDAQ) is .


SEC-8K** Filing Available For CELLDEX THERAPEUTICS INC (CLDX:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.